---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-24-000033"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:55:21.885645+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q3 GAAP EPS $0.07, Adjusted EPS $1.09; records $1.1B premium deficiency reserve

## Summary
- Total revenues $95.4B (+6.3% YoY); GAAP diluted EPS $0.07 vs $1.75 prior year.
- Adjusted EPS $1.09 vs $2.21 prior year; operating income $832M down from $3.69B.
- Health Care Benefits segment recorded ~$1.1B premium deficiency reserves ($0.63/share) for Medicare and individual exchange.
- Year-to-date cash flow from operations $7.2B; CEO highlights strong Health Services and Pharmacy segments but challenges in Health Care Benefits.

## SEC filing metadata
- accession: 0000064803-24-000033
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480324000033/0000064803-24-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480324000033/cvs-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-24-000033
- JSON: https://secwatch.observer/filing/0000064803-24-000033.json
- Plain text: https://secwatch.observer/filing/0000064803-24-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.